What is the ROCE (Return on Capital Employed) of Pulmonx this year?
The ROCE of Pulmonx is -0.65 undefined this year.
Pulmonx ROCE 2025
Pulmonx ROCE
-0.65
Ticker
LUNG
ISIN
US7458481014
WKN
A2P1AF
In 2025, Pulmonx's return on capital employed (ROCE) was -0.65, a 24.68% increase from the -0.52 ROCE in the previous year.
Pulmonx Aktienanalyse
What does Pulmonx do?
Pulmonx Corp is an innovative medical technology company based in the USA and Europe. The company specializes in the development of non-invasive solutions for the treatment of lung diseases. Pulmonx was founded in 1997 and has since introduced numerous groundbreaking technologies to the market that improve the quality of life for patients with chronic lung diseases. Pulmonx ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Pulmonx's Return on Capital Employed (ROCE)
Pulmonx's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Pulmonx's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Pulmonx's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Pulmonx’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Pulmonx stock
How has the ROCE (Return on Capital Employed) of Pulmonx developed compared to the previous year?
The ROCE of Pulmonx has increased by 24.68% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Pulmonx?
A high Return on Capital Employed (ROCE) indicates that Pulmonx has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Pulmonx?
A low ROCE (Return on Capital Employed) can indicate that Pulmonx has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Pulmonx impact the company?
An increase in the ROCE of Pulmonx can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Pulmonx affect the company?
A decrease in ROCE of Pulmonx can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Pulmonx?
Some factors that can affect Pulmonx's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Pulmonx so important for investors?
The ROCE of Pulmonx is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Pulmonx take to improve the ROCE?
To improve the ROCE, Pulmonx can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Pulmonx pay?
Over the past 12 months, Pulmonx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pulmonx is expected to pay a dividend of 0 USD.
What is the dividend yield of Pulmonx?
The current dividend yield of Pulmonx is .
When does Pulmonx pay dividends?
Pulmonx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Pulmonx?
Pulmonx paid dividends every year for the past 0 years.
What is the dividend of Pulmonx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Pulmonx located?
Pulmonx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Pulmonx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Pulmonx from 10/9/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/9/2025.
When did Pulmonx pay the last dividend?
The last dividend was paid out on 10/9/2025.
What was the dividend of Pulmonx in the year 2024?
In the year 2024, Pulmonx distributed 0 USD as dividends.
In which currency does Pulmonx pay out the dividend?
The dividends of Pulmonx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Pulmonx
Our stock analysis for Pulmonx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pulmonx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
